Iradimed (IRMD) Cash from Operations Growth (5y) (2018 - 2026)
Iradimed (IRMD) Cash from Operations Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Iradimed | 1.22 Bn | 1.17 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.45% |
| Dec 31, 2025 | 18.86% |
| Sep 30, 2025 | 39.25% |
| Jun 30, 2025 | 57.84% |
| Mar 31, 2025 | 29.10% |
| Dec 31, 2024 | 8.68% |
| Sep 30, 2024 | 23.77% |
| Jun 30, 2024 | 21.76% |
| Mar 31, 2024 | 42.31% |
| Dec 31, 2023 | 2.01% |
| Sep 30, 2023 | 13.86% |
| Jun 30, 2023 | 18.22% |
| Mar 31, 2023 | 24.01% |
| Dec 31, 2022 | 16.75% |
| Sep 30, 2022 | 15.60% |
| Jun 30, 2022 | 41.25% |
| Mar 31, 2022 | 57.60% |
| Dec 31, 2021 | 8.64% |
| Sep 30, 2021 | -0.25% |
| Jun 30, 2021 | 21.84% |